Product Images Guanfacine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Guanfacine Hydrochloride NDC 53746-711 by Amneal Pharmaceuticals Of New York Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

1 - guanfacine tablet usp india 1

1 - guanfacine tablet usp india 1

1 - guanfacine tablet usp india 2

1 - guanfacine tablet usp india 2

This is a description of Guanfacine Tablets, USP manufactured by Amneal Pharmaceuticals Pvt. Ltd. The tablets come in a bottle of 100 and each tablet contains 1.15 mg of guanfacine hydrochloride. The usual dosage and complete product information can be found in the package insert. The tablets should be stored at a temperature of 20-25°C (68-77°F) and dispensed in a light-resistant container with a child-resistant closure as defined in the USP. The tablets are an oral solid dosage unit and are distributed by Rev. 08-2021-00. The lot and expiration date can be found in a non-varnish area on the bottle.*

2 - guanfacine tablet usp india 3

2 - guanfacine tablet usp india 3

Guanfacine Tablets, USP, containing 2 MG of guanfacine hydrochloride, are packaged in a child-resistant, light-resistant container with dosage instructions provided in the package insert. The tablets should be stored at a temperature of 20-25°C. Dispensed by Amneal Pharmaceuticals, the product is manufactured in Ahmedabad, India, and distributed in Bridgewater, NJ. Lot and expiration dates are printed in the non-varnish area (24 x 38 mm) on the packaging.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.